logo

For the Inventor, By the Inventor

San Mateo, CA, United States of America

Afferent Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 12



Forward Citations = 28

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Anthony P Ford (12 out of 21 patents)

silverMedal Prabha N Ibrahim (6 out of 134 patents)

bronzeMedal Ronald Charles Hawley (6 out of 57 patents)

4.  Joel R Gever (4 out of 5 patents)

5.  Steven A Smith (3 out of 5 patents)

6.  Bruce G McCarthy (3 out of 3 patents)

7.  Julian Paton (2 out of 2 patents)

8.  Kathleen Sereda Glaub (1 out of 1 patent)

9.  Michael M Kitt (1 out of 1 patent)

10.  Bruce G Mccarthy (0 patent)

11.  Steven Smith (0 patent)


12 patents:

1. 11260056 - Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough (2022-03-01),
2. 11230533 - Crystalline salts and polymorphs of a P2X3 antagonist (2022-01-25),
3. 11230532 - Pyrimidines and variants thereof, and uses therefor (2022-01-25),
4. 10988460 - Substituted pyrazole-pyrimidines, variants thereof, and uses therefore (2021-04-27),
5. 10822311 - Pyrimidines and variants thereof, and uses therefor (2020-11-03),
6. 10676444 - Crystalline salts and polymorphs of a P2X3 antagonist (2020-06-09),
7. 10662162 - Pyrimidines and variants thereof, and uses therefor (2020-05-26),
8. 10543211 - Methods and compositions for treating diseases and conditions (2020-01-28),
9. 10206922 - Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough (2019-02-19),
10. 10195198 - Methods and compositions for treating diseases and conditions (2019-02-05),
11. 9724346 - Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough (2017-08-08),
12. 9284279 - Substituted pyrimidines for treatment of acute cough, chronic cough and urge to cough (2016-03-15),
Company Overview
Afferent Pharmaceuticals, Inc. is a biotechnology company based in San Mateo, California, focused on developing innovative therapies for neurological disorders. The company specializes in the discovery and advancement of novel drug candidates that target specific pathways involved in pain and other sensory disorders. Afferent's research leverages cutting-edge science to address unmet medical needs, aiming to improve the quality of life for patients suffering from chronic conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

12 Patents

#70 in San Mateo, CA

#6,072 in California

#25,614 in US

#48,276 in the World

San Mateo, CA (US)
San Mateo, CA, United States of America

Afferent Pharmaceuticals, Inc.

Forward Citations = 28

9 inventors:

goldMedal Anthony P Ford (12 out of 21 patents)

silverMedal Prabha N Ibrahim (6 out of 134 patents)

bronzeMedal Ronald Charles Hawley (6 out of 57 patents)

4.  Joel R Gever (4 out of 5 patents)

5.  Steven A Smith (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Afferent Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/afferent-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…